455,188 HIV medication bottles arrive in the Philippines

The Department of Health said 455,188 anti-retroviral bottles for treating people living with HIV have arrived in the Philippines. The medicines are scheduled for distribution next week.

The DOH said the Lamivudine+Tenofovir+Dolutegravir or LTD passed inspection and is safe, effective, high-quality and registered with the Food and Drug Administration.

It is expected that the first tranche of HIV ARVs will be completed in the coming weeks and will also undergo inspection. The second and third tranches are expected to arrive in August and September this year.

Supplier Phil Pharmawealth will bring in 1.2 million bottles of LTD in total. The first batch of 600,000 bottles was set for delivery last May but delayed after the supplier cited the Middle East crisis.

Liittyvät artikkelit

Chilean Air Force plane taking off with humanitarian aid to Venezuela
AI:n luoma kuva

Chile sends third humanitarian flight to Venezuela with vaccines and medicines

Raportoinut AI AI:n luoma kuva

A Chilean Air Force plane took off Friday night bound for Caracas carrying 35,000 vaccines, medicines, food and aid kits.

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

Raportoinut AI

South Africa has started rolling out the twice-yearly HIV prevention injection lenacapavir, though success depends on managing interactions with common tuberculosis medicines.

The Ethiopian Pharmaceutical Supply Services has proposed a multi-vendor procurement system to tackle ongoing medicine sourcing challenges. The system has yet to be implemented.

Raportoinut AI

Two patients, known as Ascent and Kansas City, will be presented as the 12th and 13th cases of HIV cure or prolonged remission after stem cell transplants during an international AIDS conference in Rio de Janeiro.

The Department of Health has confirmed there are no Ebola cases in the Philippines amid an outbreak of the Bundibugyo virus in the Democratic Republic of Congo.

Raportoinut AI

Pharco Pharmaceuticals plans to invest around EGP 1.5bn next year, up from about EGP 1.15bn in 2025, to expand production capacity and strengthen its presence in domestic and export markets, Chairperson Sherine Helmy said. The company is prioritising improvements in product quality alongside expansion and diversification of production lines.

 

 

 

Tämä verkkosivusto käyttää evästeitä

Käytämme evästeitä analyysiä varten parantaaksemme sivustoamme. Lue tietosuojakäytäntömme tietosuojakäytäntö lisätietoja varten.
Hylkää